The high likelihood of baseline metastasis for patients not receiving prophylactic G-CSF and receiving chemotherapy regimens with intermediate FN risk was observed only for breast cancer but was not evident among other cancer types (Table 1, Online Resource 8). Here, CSF3 is linked to breast cancer.